Ken Griffin Qiagen N.V. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$35.55 - $43.57 $1.77 Million - $2.17 Million	-49,900 Reduced 78.34%	13,800 $599,000
Q3 2023 Nov 14, 2023	BUY	$39.13 - $47.24 $1.89 Million - $2.28 Million	48,300 Added 313.64%	63,700 $2.58 Million
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $259,187 - $275,884	5,900 Added 62.11%	15,400 $693,000
Q1 2023 May 15, 2023	SELL	$45.29 - $50.76 $2.1 Million - $2.36 Million	-46,400 Reduced 83.01%	9,500 $436,000
Q4 2022 Feb 14, 2023	SELL	$41.91 - $50.48 $2.41 Million - $2.91 Million	-57,600 Reduced 50.75%	55,900 $2.79 Million
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $1.51 Million - $1.86 Million	36,900 Added 48.17%	113,500 $4.69 Million

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.96B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.